Latest news with #ColinLeeSoonSoo
The Star
29-07-2025
- Business
- The Star
Alpha IVF sets up second facility in the Philippines
PETALING JAYA: Alpha IVF Group Bhd is establishing a new full-fledged fertility treatment centre in Tuguegarao, the Philippines, marking the group's second planned facility in the country. In a statement, the fertility care specialist said the new centre advances the group's mission to broaden access to assisted reproductive services across the region. Alpha IVF said the centre would provide minimally invasive surgery in gynaecology, which is expected to contribute significantly to the centre's revenue. 'Tuguegarao, a rapidly developing urban hub in northern Luzon, has a substantially underserved healthcare sector, with a growing middle-income demographic and a catchment population of 23.2 million, our centre will be the first and only IVF facility in the northern half of Luzon – Philippines' most populous island – positioning us to meet the increasing demand for advanced fertility care. 'The upcoming centre, targeted to be operational by the fourth quarter of 2026 (4Q26), will strategically complement the group's upcoming centre in Manila, to be launched by October 2025, as it grows its footprint in the Philippines,' the company said. Group managing director Datuk Dr Colin Lee Soon Soo said the expansion into Tuguegarao allowed the company 'to make a tangible difference where demand for fertility treatment is significant, but access is limited.' 'Our mission is to bridge these accessibility gaps, reflecting our disciplined approach to investing in strategic locations that allow us to deliver world-class care, empowering more families across South-East Asia to achieve their dream of parenthood,' he added. Separately Alpha IVF announced that it achieved its highest-ever profit after tax and minority interests (patmi) of RM57.5mil in the financial year ended May 31, 2025 (FY25) – a 8.5% increase from RM52.9mil in the previous year. 'The strong bottom-line performance was supported by revenue growth of 5.5% to RM176.8mil in FY25 from RM167.6mil in the previous year, led by the group's Malaysia operations, particularly the foreign patient segment.' The company said Malaysia operations contributed RM157.2mil, or 88.9% of the group's total revenue in FY25 – a 16% increase from RM135.5mil in the previous year, or 80.9% of the group's total revenue. The group's Singapore operations contributed the remaining RM19.6mil, according to the statement. In the fourth quarter ended May 31, 2025, the group's revenue rose 7% year-on-year to RM50mil from RM46.7mil previously, while patmi saw a 14.7% increase to RM16.1mil from RM14mil in the corresponding quarter of the previous year. The group has declared a second interim dividend of 0.50 sen per share in respect of FY25, payable on Aug 29. 'Together with the first interim dividend of 0.50 sen per share paid on Dec 31, 2024, the total dividends for FY25 amount to one sen per share, representing a payout of RM48.6mil or 84.6% of patmi. 'This is well above the group's commitment to distribute at least 60% of its annual patmi for shareholders.'
The Sun
23-07-2025
- Business
- The Sun
Alpha IVF opens satellite clinic in Surabaya, its second in Indonesia
PETALING JAYA: Fertility care specialist Alpha IVF Group Bhd has opened its second satellite clinic in Surabaya, Indonesia, its second in the country. The expansion forms part of the group's initial public offering roadmap to establish four satellite clinics in Indonesia, strengthening its regional growth strategy and deepening its footprint in the country, which is one of the group's fastest-growing international markets. Group managing director Datuk Dr Colin Lee Soon Soo said Surabaya was strategically chosen to expand the company's reach into East and Central Java, where it sees strong potential for growth in fertility treatment. 'Our first satellite clinic in Jakarta began showing results in less than three months of operations, which gives us strong confidence in the scalability and effectiveness of our satellite model. 'We believe the Surabaya clinic will build on this momentum and further increase patient referrals to our flagship centres in Malaysia,' he said in a statement. The new clinic is strategically located within the Womba Women's and Children Specialist Clinic in Surabaya. Situatedin the heart of East Java, Surabaya – the second largest city in Indonesia after Jakarta – was selected to meet the growing demand for assisted reproductive services across the region, including nearby urban centres such as Solo, Semarang and Yogyakarta. The clinic will serve as a key referral and patient coordination centre, offering initial consultations and fertility assessments, while seamlessly connecting patients to Alpha IVF's flagship centres in Malaysia for comprehensive treatment. Alpha IVF's first Indonesian satellite clinic, located in Pantai Indah Kapuk, Jakarta, commenced operations in May and has already shown encouraging results. In less than three months, 29 couples have been referred to the group's Malaysia-based centres, demonstrating early validation of the group's regional strategy. Alpha IVF expects its Indonesia-based satellite clinics, including those in Jakarta and Surabaya, to make a meaningful contribution to cross-border patient volume and revenue growth. Apart from Indonesia, Alpha IVF currently operates in Malaysia, Singapore and China. The group has pioneered numerous innovations leading to improved pregnancy rates and is actively involved in utilising advanced artificial intelligence technology to enhance embryo selection for higher IVF success rates.
The Star
22-04-2025
- Business
- The Star
Alpha IVF Group eyes regional expansion
The company's revenue for 3Q24 grew 12.2% to RM43.24mil. KUALA LUMPUR: Alpha IVF Group Bhd is targeting to operate a total of at least 15 facilities, covering Malaysia, Indonesia, China, the Philippines, and Singapore by the financial year ending May 31, 2027. The fertility care specialist currently operates four full-fledged IVF centres across Malaysia and Singapore, along with two sales and representative offices in China. For the next 12 months, Alpha IVF expects two additional IVF centres in Malaysia, two IVF centres in South East Asia and four satellite clinics in Indonesia will be operational, it said in a filing with Bursa Malaysia. In the third quarter ended Feb 28 (3Q25), Alpha IVF posted a lower net profit of RM11.9mil, or earnings per share of 0.24, compared with RM13.6mil, or 0.30 sen in the year-ago quarter. Revenue for the quarter stood at RM40.6mil against RM40.7mil posted last year. In the nine months to Feb 28, the group posted a net profit of RM41.4mil, up 6.3% from RM38.9mil a year ago, while revenue rose 5% to RM126.8mil from RM120.8mil previously. Alpha IVF attributed the improved performance primarily to continued growth in its foreign patient segment within its Malaysian operations during the period. The growing foreign patient base underscores Alpha IVF Group's strong regional presence and reputation for delivering world-class fertility care. 'As we move forward, our strategy remains consistent – to grow both organically via our existing centres and through regional expansion initiatives. 'We believe the steps we are taking to expand access to our fertility treatment services in the region will not only strengthen our regional presence but also deliver long-term value for our shareholders,' group managing director Datuk Dr Colin Lee Soon Soo said in a statement.
